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Key messages
 ► Accurate data on tuberculosis (TB) incidence in 
infants in India, a country with the highest glob-
al burden of TB cases, and information on optimal 
surveillance strategies is pertinent to designing TB 
vaccine trials.
 ► The overall TB case-finding rate was 3.19 per 100 
person-years (95% CI 0.82 to 18.1). Active surveil-
lance increased the case-finding rates for proba-
ble TB and was associated with reduced all-cause 
mortality.
 ► The results inform the monitoring of TB in a high-risk 
population and the planning of TB vaccine trials and 
other prevention strategies in Indian infants and in 
other high-burden TB settings.
AbstrAct
Introduction Accurate tuberculosis (TB) incidence and 
optimal surveillance strategies are pertinent to TB vaccine 
trial design. Infants are a targeted population for new 
TB vaccines, but data from India, with the highest global 
burden of TB cases, is limited.
Methods In a population-based prospective trial 
conducted between November 2006 and July 2008, 
BCG-vaccinated neonates in South India were enrolled 
and cluster-randomised to active or passive surveillance. 
We assessed the influence of surveillance strategy on 
TB incidence, case-finding rates and all-cause mortality. 
Predefined criteria were used to diagnose TB. All deaths 
were evaluated using a verbal autopsy.
results 4382 children contributed to 8164 person-years 
(py) of follow-up (loss to follow-up 6.9%); 749 children 
were admitted for TB evaluation (active surveillance: 
641; passive surveillance: 108). The TB incidence was 
159.2/100 000 py and the overall case-finding rate was 
3.19 per 100 py (95% CI 0.82 to 18.1). Whereas, the 
case-finding rate for definite TB was similar using active 
or passive case finding, the case-finding rate for probable 
TB was 1.92/100 py (95% CI 0.83 to 3.78) with active 
surveillance, significantly higher than 0.3/100 py (95% CI 
0.01 to 1.39, p=0.02) with passive surveillance. Compared 
to passive surveillance, children with active surveillance 
had decreased risk of dying (OR 0.68, 95%CI 0.47 to 0.98) 
which was mostly attributable to reduction of death from 
pneumonia/respiratory infections (OR 0.34, 95%CI 0.14 to 
0.80).
conclusion We provide reliable estimates of TB 
incidence in South Indian children <2 years of age. Active 
surveillance increased the case-finding rates for probable 
TB and was associated with reduced all-cause mortality.
IntroductIon
Accurate tuberculosis (TB) incidence esti-
mates in children are essential in addressing 
the TB epidemic: (1) to guide and evaluate 
programmes of TB control and (2) for plan-
ning and evaluation of TB vaccine trials 
conducted in this age group.1 However, many 
countries do not require notification of TB 
in children given the paucibacillary nature 
of childhood TB, associated diagnostic chal-
lenges2 and the assumed reduced risk of 
transmission. These issues have resulted in a 
lower priority for case finding, diagnosis and 
treatment of paediatric TB by the WHO and 
by National TB Control Programs (NTCP). 
More recently the WHO has called for more 
accurate estimates of the burden of TB in 
children,3 including TB incidence in chil-
dren aged <5 years, since young children 
have a high risk of developing TB following 
Mycobacterium tuberculosis (MTB) infection.2 
Efficacious TB vaccines are urgently needed 
in children as the BCG vaccine has demon-
strated variable efficacy in different popu-
lations in preventing MTB infection and 
disease progression.4 Reliable estimates of TB 
incidence in target populations and efficacy 
estimates of TB vaccine candidates depend 
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on notification of true TB cases, which is best achieved 
through prospective cohort studies; globally, few studies 
have been conducted.5 6 Sample size estimates for vaccine 
trials depend on accurate surveillance and optimised 
case detection. This was addressed by the South African 
Tuberculosis Vaccine Initiative (SATVI) in a neonatal 
cohort study using active and passive surveillance similar 
to the present study.7
New TB vaccine candidates should be tested in India 
as a priority, given that India has the largest number of 
estimated incident TB cases globally (2.79 million)8 and 
bears 27% of the estimated burden of paediatric TB cases 
of the 22 high-endemic countries.9 India does not meet 
the global target for case detection and rates among 10 
countries which account for 76% of the gap between 
case notification rates and estimated incidence.8 Further-
more, the models for TB incidence rates in children 
do not take into account specific predisposing factors 
in Indian children, including high burden of malnutri-
tion,10 suggesting an overall underestimation of TB cases.
Our main objective was therefore to determine the TB 
incidence between birth and 2 years of age in children 
vaccinated at birth with BCG. Furthermore, we hypothe-
sised that TB case-finding rates and the clinical presenta-
tion of TB disease is influenced by surveillance strategy. 
We therefore conducted a population-based prospec-
tive trial of neonates cluster randomised to bimonthly 
home visits (active surveillance) or parental seeking 
of healthcare after education (passive surveillance) in 
Southern India. In the context of a large prospective trial 
of a vulnerable group with known high mortality, our 
secondary objective was to assess the impact of surveil-
lance strategy on all-cause mortality.
Methods
trial design
A prospective stratified cluster randomised trial with 
enrolment between November 2006 and July 2008. The 
study close-out was completed September 2010.
trial setting
This study was conducted in Palamaner, Chittoor 
District, Andhra Pradesh, India, a study area covering 
a population of approximately 400 000 in 800 villages 
and 4 towns, where resident women were estimated to 
give birth to 4000–4500 neonates annually. The study 
area had 13 primary healthcare centres, 2 subdistrict 
level government hospitals, 4 private nursing homes/
hospitals, 5 TB microscopy centres, 3 Directly Observed 
Treatment (DOT) centres and a private medical college 
hospital. A study-specific Case Verification Ward (CVW) 
was established at Emmaus Swiss Referral Hospital. The 
HIV prevalence in women attending antenatal clinics was 
0.53% in 2012.11 BCG vaccination is recommended for 
children below 1 month of age,12 and coverage is above 
90% in all populations of children<2 years except within 
the Muslim minority (81.4%).13 Pregnant women within 
the study area were identified antenatally and informed 
about the study (n=7424).
eligibility and surveillance for all participants
Neonates were eligible if they received routine BCG 
vaccine I.P. (Serum Institute of India, Pune) within 72 
hours of birth (0.05 mL administered intradermally 
by the study team) and their families had no intention 
to move. All parents/caretakers were educated about 
TB-related symptoms and encouraged to contact a study 
worker or visit the CVW (transportation free of cost), if 
their children developed symptoms suggestive of TB or 
were exposed to a TB case.
Admissions and deaths at health centres within the 
study area and in referral hospitals in close proximity 
were screened weekly by the study team.
The close-out visit (day 720) included a Tuberculin 
Skin Test (TST) and screening for defined referral 
criteria (figure 1), when if present led to a full diagnostic 
assessment at the CVW.14 This included assessment of 
symptoms, clinical examination including anthropom-
etry, chest X-ray and collection of microbiological speci-
mens (induced sputum and gastric aspirates collected on 
two consecutive days) and a TST (figure 1). For children 
who died during the study period, a verbal autopsy (a 
questionnaire modified from a previous Indian study;15 
online supplementary file 1) assessed probable cause of 
death if the parents/caretakers consented.
type of surveillance
Both arms included parental education about TB symp-
toms at inclusion. Trained study field workers16 supported 
each of the two surveillance arms:
Active surveillance: At a bimonthly home visit, a study 
field worker enquired about TB-related symptoms and 
recent TB exposure, recorded the weight of the child 
(calibrated spring balance) on a WHO gender-specific 
growth chart.17 If referral criteria14 were present, the 
field worker encouraged, repeatedly if needed, that the 
parent/caretaker brings the child to the CVW.
Passive surveillance: No home visits were performed.
randomisation
Stratified cluster randomisation was chosen in order to 
avoid migration from passive to active surveillance while 
ensuring a balance between different levels of develop-
ment of villages and population sizes. A total of eight 
strata were defined according to the level of development 
of villages and population size: (1) rural-high small, (2) 
rural-high medium, (3) rural-high large, (4) rural-low 
small, (5) rural-low medium, (6) rural-low large, (7) 
urban-medium and (8) urban-large. Each stratum had 
its own randomisation list. Within each stratum clusters 
were defined as population units consisting of villages 
or subsections of towns (based on Census of India divi-
sions). A total of 592 clusters were used (see online 
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Figure 1 Criteria for referral to the CVW at Emmaus Swiss Hospital, Palamaner (CVW) and the diagnostic algorithm applied 
for the classification of definite (confirmed) and probable (unconfirmed) TB. CVW, Case Verification Ward; GA, gastric aspirate; 
MTB, Mycobacterium tuberculosis; NAA, nucleic amplification assay; TB, tuberculosis; TST, Tuberculin Skin Test;
supplementary file 2). Within each stratum, clusters were 
manually picked (‘out-of-a-hat’) and alternately allocated 
to active and passive surveillance by two field supervisors 
according to the corresponding randomisation list.
outcomes
Based on a predefined diagnostic algorithm (figure 1), 
the children were classified as having definite TB, prob-
able TB or no TB using a diagnostic algorithm,14 similar 
to that of the neonatal study conducted by SATVI.7 
Definite and probable TB cases constituted the primary 
outcome ‘all TB cases’. All children given a diagnosis of 
definite or probable TB were referred to the RNTCP 
for treatment. MTB infection as judged by TST was 
performed in admitted children and per protocol on 
the close-out visit as described and judged positive if 
≥10 mm as recommended by Indian guidelines.18
sample size
No formal sample size calculation was performed for 
the outcomes definite/probable TB and MTB infec-
tion, due to the lack of reliable data on TB incidence 
in both adults and children in the district in 2006 
when the study was initiated. Preliminary results from 
a similar study in South Africa showed a risk of definite 
TB in neonates of 2.3%.7 The overall reported TB inci-
dence in South Africa was ~3.5 times the incidence in 
India,19 translating into >25 expected TB cases in the 
present target cohort of 4000–4500 neonates.
Parents/caretakers gave written consent for their chil-
dren to be enrolled.16 Additional consent was obtained 
for the diagnostic procedures undertaken.
data management and statistical analysis
Data were entered on case report forms (CRFs) and 
checked for completeness and double-entered into 
a customised data management software (using the 
Microsoft SQL server (MS-SQL 2000) and ASP.Net 
as the programming tool). Any data mismatch was 
resolved against the original CRF. A final 10% quality 
check was performed prior to import into Microsoft 
Excel and SPSS (V.23) for analysis.
Baseline characteristics of birth and socioeconomic 
status (SES), data on TB exposure, TST and attrition 
rate were summarised as counts and percentages. Vari-
ables recording housing material and cooking fuel were 
dichotomised (bricks vs others; electricity or gas vs others, 
respectively). Intervention groups were compared in 
the entire cohort by means of Pearson χ² tests.
Differences between surveillance arms in clinical char-
acteristics at the CVW, admission and referral criteria, 
study drop-outs (all reasons), causes of death and prev-
alence of MTB infection, were analysed using logistic 
mixed-effects regression models including adjustments 
for cluster-specific random effects and fixed effects of 
age (only at the time of the CVW visit), gender, religion 
and father’s education (as assessed by literacy) and 
fuel. Results were reported as OR with corresponding 
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Figure 2 Flowchart for enrolment in the Neonatal Cohort Study. CVW, Case Verification Ward.
95% CI. Mean follow-up times were compared using a 
similar linear mixed model.
The TB case-finding rates were calculated using 
Poisson regression and person-years (py) of follow-up. 
Py were calculated from the date of birth until the date 
of TB diagnosis, death, close-out visit or withdrawal, 
whichever event came first. For participants lost to 
follow-up, py were calculated as midway between the 
last contact date and date of the next expected visit. 
Sensitivity analyses under various assumptions about 
length of follow-up and TB status were also performed.
results
birth and socioeconomic characteristics in the study cohort
Of the eligible neonates, 4 872 had parents available 
for consent query within 15 days of birth. Non-avail-
ability for consent was largely due to the practice of 
women travelling to their mother’s homes to deliver. 
The 4382 participants, who enrolled, corresponded to 
a response rate of ~90%. Of these 2215 neonates were 
cluster randomised to active and 2167 neonates to 
passive 2-year surveillance (figure 2) and 2276 (51.9%) 
were boys. Cluster randomisation succeeded in similar 
distributions of most baseline characteristics between 
the surveillance groups. However, the passive surveil-
lance group contained more Hindus (p<0.001), lower 
paternal literacy (p=0.002) and higher use of wood/
agricultural residues for fuel (p<0.001) (table 1).
study attrition
Of the enrolled children, 90.4% completed the 2-year 
follow-up, corresponding to a study attrition rate of 
9.6% (table 2). Mean follow-up time was 22 months 
(SD 4.25), but influenced by surveillance strategy 
when adjusted for SES factors (mean 22.2 (active) vs 
21.8 (passive), estimate −0.39, SE 0.13, 95% CI −0.65 
to −0.14).
characteristics of children evaluated for tb during the study 
period
Referral and admission was seven times more likely 
under active compared with passive surveillance (ORre-
ferral 7.38, 95% CI 6.21 to 8.77; ORadmission 7.9, 95% CI 6.37 
to 9.79). The major difference in referral and admis-
sion rates between the active vs passive surveillance 
arms was accounted for by those children referred with 
failure to thrive (FTT) (33.5% of those referred were 
not admitted); children with FTT in the passive surveil-
lance arm were less likely to be brought to the CVW 
by their parents/caretakers. Otherwise, the referral 
criteria were evenly distributed within the surveillance 
arms.
Children in the passive surveillance arm were evalu-
ated at an older age than children in the active surveil-
lance arm (mean age 20.3 vs 13.3 months, estimate 
7.31, 95% CI 6.20 to 8.42), were four times more likely 
to have FTT and less likely to have known TB exposure, 
abnormal chest X-ray and TST ≥10 mm (online supple-
mentary file 3).
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Table 1 Distribution of birth and socioeconomic characteristics at enrolment in the intervention arms
Surveillance 
Total (N=4382) Active (N=2215) Passive (N=2167)
n (%) n (%) n (%)
  Gender (Boys) 2276 (51.9) 1132 (51.1) 1144 (52.8)
Birth factors
  Birth weight
   <2500 g 430 (9.8) 210 (9.5) 220 (10.2)
   =2500 g 846 (19.4) 415 (18.8) 431 (19.9)
   >2500 g 3096 (70.8) 1584 (71.7) 1512 (69.9)
  Type of delivery
   Normal 3839 (87.6) 1920 (86.7) 1919 (88.6)
   Caesarean section 543 (12.4) 295 (13.3) 248 (11.4)
Socioeconomic characteristics
  Religion
   Hindu 3751 (85.6) 1846 (83.3) 1905 (87.9)
   Others* 631 (14.4) 369 (16.7) 262 (12.1)
  Caste
   Dalit/Harijan† 850 (19.4) 441 (19.9) 409 (18.9)
   Others 3528 (80.5) 1772 (80.0) 1756 (81.0)
  Highest education achieved by mother
   Illiterate 1337 (30.5) 652 (29.4) 685 (31.6)
   Primary (upto class 5) 1251 (28.5) 615 (27.8) 636 (29.3)
   Secondary (upto class 7) 803 (18.3) 416 (18.8) 387 (17.9)
   High School (upto class 10) 729 (16.6) 394 (17.8) 335 (15.5)
   Higher secondary (class 11–12) 151 (3.4) 76 (3.4) 75 (3.5)
   College 111 (2.5) 62 (2.8) 49 (2.3)
  Highest education achieved by father
   Illiterate 979 (22.4) 453 (20.5) 526 (24.3)
   Primary 1083 (24.8) 561 (25.4) 522 (24.1)
   Secondary 1021 (23.4) 513 (23.3) 508 (23.5)
   High school 896 (20.5) 475 (21.5) 421 (19.5)
   Higher secondary 209 (4.8) 101 (4.6) 108 (5.0)
   College 181 (4.1) 103 (4.7) 78 (3.6)
  Fuel used for cooking‡
   LPG§/Gas 333 (7.6) 211 (9.5) 122 (5.6)
   Others 4049 (92.4) 2004 (90.5) 2045 (94.4)
  Type of walls of the house¶
   Brick 3338 (76.2) 1707 (77.1) 1631 (75.3)
   Others 1044 (23.8) 508 (22.9) 536 (24.7)
Exposure to TB
  TB in household past 1 year 42 (1.0) 25 (1.1) 17 (0.8)
  Current TB in household 28 (0.6) 10 (0.5) 18 (0.8)
*Others included Muslims (14.0%) and Christians (0.4%).
†Hindu's not belonging to a caste.
‡Wood is used as a low socioeconomic indicator, higher socioeconomic groups would use kerosene, electricity and LPG.
§Liquefied petroleum gas.
¶Brick is used as high socioeconomic indicator, low socioeconomic groups would have walls made of mud, bamboo and so on.
**Reported as number of population unit. Details of population units are given in the text.
††The Active surveillance group had a 2 monthly home visit by a study team field worker. The passive surveillance group were contacted only at the 
start of the study and at study close out.
LPG, liquefied petroleum gas; TB, tuberculosis.
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Table 2 Study attrition in total and within each surveillance arm
Total (N=4382)
n (%)
Surveillance 
Active (N=2215)
n (%)
Passive (N=2167)
n (%) OR (95% CI)* 
Death 120 (2.7) 49 (2.2) 71 (3.3) 0.68 (0.47 to 0.98)
Lost to follow-up 98 (2.2) 38 (1.7) 60 (2.8) 0.62 (0.41 to 0.94)
With drawn 204 (4.7) 93 (4.2) 111 (5.1) 0.84 (0.63 to 1.11)
Children completing the study 3960 (90.4) 2035 (91.9) 1925 (88.8) 1.24 (0.94 to 1.63)
Data are shown as number and percentages within parenthesis.
*OR and 95% CI estimates of the effect of active surveillance corrected for cluster-specific random effects and the fixed effects of gender, 
religion, father’s education and fuel applying mixed-effects logistic regression are shown. Significant differences are bolded.
tb incidence and case-finding rates in the surveillance 
groups
TB was confirmed in four children and probable TB was 
diagnosed in nine children. The distributions of TB cases 
for the surveillance arms are given in table 3. Based on 
8164 py (active: 4166 py, passive: 3998 py), the estimated 
overall TB incidence was 159.2 per 100 000 (95% CI 
92.5 to 274.1). The overall case-finding rate was 3.19 per 
100 py (95% CI 0.82 to 18.1, p=0.06). Whereas the case-
finding rate for definite TB was similar between surveil-
lance groups, the case-finding rate for probable TB was 
significantly higher with active surveillance (1.92/100 vs 
0.3/100 py, p=0.02).
The four sensitivity analyses gave very similar results, 
with case-finding rates ranging from 0.73 to 3.27 py (none 
of the p<0.05; online supplementary file 4).
Prevalence of Mtb infection in the cohort at study closure
In the 3961 children completing the study, the preva-
lence of MTB infection as judged by a TST ≥10 mm18 was 
2.9% in the entire cohort and comparable between the 
surveillance arms, despite TB exposure more frequently 
being reported in the active surveillance arm (3.8% vs 
1.4%, OR 3.02, 95% CI 1.95 to 4.67).
Mortality
Out of 120 children who died, the causes of death were 
evaluated by verbal autopsy in 110 children. Neonatal 
deaths (within 27 days of birth) and postnatal deaths 
(≥28 days from birth) constituted 23.3% and 76.7% of 
deaths, respectively. Children with active surveillance 
had reduced risk of dying and were less frequently lost to 
follow-up (table 2).
Furthermore, the death-rate was reduced in active 
surveillance and this was mostly attributable to reduction 
of death from pneumonia/respiratory infections (OR 
0.34, 95% CI 0.14 to 0.80; online supplementary file 5) 
. Notably, only one of the children who died had known 
TB exposure. This child was evaluated at the CVW at the 
age of 5 months because of respiratory symptoms (TST 
4 mm, CXR normal, neg IS/GA specimen), 17 months 
before death.
dIscussIon
To design and implement adequately powered trials of 
novel TB vaccine candidates, local, accurate estimates of 
TB incidence are required. The present study is the first 
to estimate the TB incidence among a general Indian 
population <3 years of age and to evaluate the impact 
of active versus passive TB case finding using prospective 
community-based cohort methods. Based on 8164 py, the 
cumulative overall TB incidence (definite and probable 
cases pooled) was 159.2 per 100 000 py. Active surveil-
lance increased the detection of probable TB cases and 
reduced all-cause mortality, specifically deaths attribut-
able to respiratory infections.
The likelihood of being referred and admitted 
was almost 7–8 times higher in children in the active 
compared with the passive surveillance arms. We 
expected that active surveillance with bimonthly home 
visits would result in the identification of more children 
meeting the defined referral criteria by regular weighing 
and by reducing the threshold for referral. Nevertheless, 
we were surprised that the effect observed in our study 
was more pronounced than in the SATVI study.7 This 
might be explained by a generally lower educational 
level (primary school or lower) in Indian mothers in this 
study (59%) compared with South African mothers in 
the SATVI study (26%)7 or other factors. Similar to Moyo 
et al,7 we found a higher case-finding rate of probable TB 
cases in the active compared with the passive surveillance 
arms likely resulting from active surveillance facilitating 
earlier diagnosis of TB and even diagnosis of early or incip-
ient disease.2 20 21 More definite TB cases could then be 
expected to develop in the context of passive surveillance 
and notified at study closure. Despite examination for 
TB in all children at study closure, this was not observed. 
Notably, the prevalence of MTB infection was similar 
in the active and passive surveillance arms, rendering a 
bias from lower SES in the passive surveillance arm on 
TB incidence estimates unlikely. Although we cannot 
verify whether the uneven distribution of probable cases 
represents a combination of overdiagnosis within the 
active and underdiagnosis within the passive surveillance 
arms, we think it unlikely that we have overestimated the 
incidence of total TB cases. The diagnostic algorithm for 
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probable TB in the study relied on the approach used 
by SATVI.5 7 More stringent criteria for case definition of 
microbiologically unconfirmed cases have been suggested 
in more recent studies6 and introduced in consensus 
guidelines.22 We acknowledge that reduced pretest prob-
ability for TB in our Indian cohort compared with South 
African cohorts is likely to have affected the accuracy 
of the diagnostic algorithm. Furthermore, there is the 
possibility that some children diagnosed with probable 
TB had symptoms of initial MTB infection which would 
have eventually resolved spontaneously.2 23 Notably, we 
previously found significant differences in the expression 
of transcriptional biomarkers between children from the 
present cohort diagnosed with either clinical TB, MTB 
infection and controls,24 which strengthens the appro-
priateness of the diagnostic algorithm applied. Even 
though there might be misclassification of cases in the 
present study, probable TB cases are expected to consti-
tute about 70% of TB cases in young children2 which 
corresponds precisely to the proportion in the current 
study. It is also worth noting that the diagnostic proce-
dures and algorithm focused on pulmonary TB implying 
a risk of underdiagnosing extrapulmonary TB which was 
reported in 8.2% of HIV-uninfected South African chil-
dren aged <3 years. Of interest, two studies conducted 
in the context of vaccine trials found the cumulative 
incidence of TB in BCG-vaccinated children<2 years 
was approximately 3%.5 6 In a more recent prospective 
study covering a population of 13 764 children<3 years 
in Southern Mozambique, presumptive TB cases (13.2% 
HIV positive) were identified by passive and/or active 
case-finding. The incidence for definite TB was 135 per 
100 000 py.23 An interesting similarity between our Indian 
cohort and the Mozambican study was the burden of 
malnutrition, but in general, it appears that the epidemi-
ological situation in most African countries is not directly 
comparable to India. Clearly, the HIV epidemic has influ-
enced TB incidence even in HIV-uninfected children by 
left-skewing the TB epidemiological age curve in areas 
of high HIV prevalence.2 In our Indian cohort, however, 
the impact of HIV infection is presumably very low.11 In 
this context, the incidence of definite TB in our Indian 
cohort of 49 per 100 000 population could be considered 
to be higher than expected.
An important finding in this study is the reduced 
all-cause mortality in children with active compared with 
passive surveillance. This was true both when assessing 
mortality with case-rates per 100 py (no adjustments 
made) and with ORs adjusted for relevant SES variables. 
Previous studies support an impact of outreach health 
programmes on infant health.25 Multiple interventions 
judged effective in reducing infant mortality26 were 
provided by our study team, regardless of surveillance. 
These included an increased number of healthcare 
workers (HCW) in the study area who visited women 
before and after delivery encouraging an institutional 
delivery and attendance to the recommended antenatal 
visits and immunisation programmes for their infants. But 
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as the HCW were instructed to continue to deliver these 
health messages throughout the study, it is likely that 
mothers/caretakers of children within the active surveil-
lance arm received these messages to a greater extent. 
Interestingly, when stratifying the cause of mortality, only 
the risk of dying attributable to pneumonia/respiratory 
infections were significantly reduced with active surveil-
lance. This is likely explained by the focus on TB and 
respiratory symptoms.
The strengths of the present study are the large number 
of neonates enrolled in a community-based study, its 
standardised procedures for referral and diagnosis,5 7 
balance between the two surveillance arms with regard 
to similar TB exposure and infection rates and low attri-
tion. Assessment of active and passive surveillance also 
allowed for evaluation of the effect of follow-up strategy 
on the detection of TB cases. Lower SES, present in the 
families/households of children in the passive surveil-
lance arm, is a well-established risk factor for TB disease27 
and mortality26 but by adjusting for differentially distrib-
uted variables (eg, religion, parental education and fuel 
for cooking) in the two surveillance arms, except for in 
the case-rate calculations, we reduce the risk of residual 
confounding. Use of cluster randomisation is a limitation, 
as it may not achieve similar distributions of variables in 
the two arms as easily as for individual randomisation; if 
possible, future studies should use more, smaller clus-
ters. Lack of data on outcome of patients with TB due to 
referral to the RNTCP for treatment is also a limitation as 
we cannot ascertain whether children classified as prob-
able TB truly had symptoms of initial MTB infection or 
other respiratory infections, which would have resolved 
spontaneously,23 or with antibiotic treatment.22 Based 
on this, we suggest that children put on treatment for 
assumed TB or other (respiratory) disease be followed 
up in future studies aiming to more firmly estimate TB 
incidence in young children.
In conclusion, we have established the TB incidence 
in an important target population for new TB vaccines: 
children<3 years in a typical rural district in Southern 
India in a community-based prospective cohort study 
of neonates. Active surveillance with regular home visits 
seems to be most appropriate in order to detect probable 
TB cases, which represent the most common presenta-
tion of TB in young children. Active surveillance was also 
associated with the benefit of reduced all-cause mortality 
in a vulnerable population, mostly due to respiratory 
infections, one of the main child killers globally.28
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